ArticlemedRxiv : the preprint server for health sciences2025
Diagnostic Yield from Screening and Health Status Burden of Outpatients at Risk for Heart Failure.
Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Heart failure (HF) is frequently underrecognized in primary care due to nonspecific symptoms and limited screening, resulting in many patients presenting with severely compromised health status (symptoms, functional ability, and quality of life) at the time of diagnosis. Objectives: To evaluate the diagnostic yield of screening outpatients at risk for HF using a noninvasive assessment of left ventricular end-diastolic pressure (LVEDP) and to describe the health status of patients newly identified with elevated LVEDP. Methods: A convenience sample of adults with diabetes mellitus (DM), chronic kidney disease (CKD), or suspected HF were screened at three primary care clinics using the Vivio System to identify patients with LVEDP >18 mmHg (positive screening). Among patients with a positive screening result, their health status was evaluated using the Kansas City Cardiomyopathy Questionnaire Overall Summary (KCCQ-OS) score. Results: Among 2040 screened patients (mean age 74±8 years; 49.8% women; 64.6% with DM; and 34.9% with CKD) 38.5% had an elevated LVEDP. Older patients, women, and those with CKD were more likely to have an elevated LVEDP (p<0.01 for all). Of 653 KCCQ-OS scores collected (mean 85±20), 31.4% had a KCCQ-OS of 100 (asymptomatic), and 26.5% had a KCCQ-OS <80, consistent with NYHA class II-IV. Conclusion: Nearly 40% of patients had a positive screening, and over two-thirds reported significant health status impairments. Combining the KCCQ with noninvasive LVEDP assessment can identify patients who may require further HF evaluation. Future studies can assess the impact of these strategies on patients' subsequent health status and clinical events.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.